MedTrace Logo

Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer

NCT00323908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 281

Last updated 2023-05-22

No results posted yet for this study

Summary

A study to examine the correlations between methylation of various genes associated with breast cancer and proliferation and cytomorphology in breast epithelial cells acquired by random periareolar fine needle aspiration of women at high risk for development of breast cancer.

Conditions

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER

  • Avon Foundation

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Johns Hopkins University

    collaborator OTHER

  • Carol Fabian, MD

    lead OTHER

Principal Investigators

  • Carol J Fabian, MD · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2008-11-30
Completion
2008-11-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00323908 on ClinicalTrials.gov